New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Tech Council of Maryland Names Winners of 27th Annual Industry Awards
-
CORRECTING and REPLACING Tech Council of Maryland Names Winners of 27th Annual Industry Awards
-
SocialRadar Launches LocationKit - the First Replacement for iOS and Android Location Services
-
Form SC 13D/A HYPERION THERAPEUTICS Filed by: New Enterprise Associates 12, Limited Partnership
-
Cartiva, Inc. Closes $8.5 Million Financing
-
Surface Oncology Appoints Detlev Biniszkiewicz as Chief Executive Officer
-
Moximed Closes $33MM Financing Round
-
CIT GAP Funds Invests in e-Kare
-
Cybera Names New CFO and EVP Administration and Secretary
-
Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors
-
Comerica Bank, Glendale Educators and Elected Officials Honor 151 Graduates of Web-Based Financial Education Program
-
Mirna Therapeutics Secures $41.8 Million Series D Financing to Advance Oncology MicroRNA Pipeline
-
CRISPR Therapeutics Raises Additional $64 Million to Translate Breakthrough CRISPR-Cas9 Technology into Next Generation Therapies for Patients
-
UPDATE - DEMO Traction 2015 Successfully Wraps Up San Francisco Conference
-
DEMO Traction 2015 Successfully Wraps Up San Francisco Conference
-
Mirna Therapeutics Presents Interim Phase 1 Data on First-in-Class, First-in-Clinic microRNA-34 Mimic, MRX34, at the 2015 Annual Meeting of the American Association for Cancer Research
-
Blend Therapeutics Presents Preclinical Data for Lead Candidate BTP-114 that Demonstrated Superiority to Cisplatin in Tumor Growth Inhibition
-
Blend Therapeutics Presents Preclinical Data for Lead Pentarin™ Program, BTP-277, Demonstrating Specific and Potent Tumor Cell Targeting for Small-Cell Lung Cancer
-
Ravel Law Announces Unprecedented Judge Analytics Offering
-
IfOnly, the Marketplace for Experiences, Is Offering a Meet & Greet with Justin Bieber and Nick Jonas at the Ultimate Wango Tango Experience on May 9th, 2015
-
Gannett partners with ViewLift to offer digital sports and entertainment video content
-
MEDIAN Technologies: 2014 Results
-
NEA Closes On More Than $3.1B In Committed Capital
-
Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer
-
CashStar Selected as an AlwaysOn OnFinance Top 100 Winner
-
Niara Closes $20m in Series B Funding to Deliver Big Data Security Analytics
-
Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
-
Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
-
Form SC 13D/A HYPERION THERAPEUTICS Filed by: New Enterprise Associates 12, Limited Partnership
-
Placester Raises $15 Million in Series B Funding
-
IIX Completes $20 Million Financing With TriplePoint Capital
-
IIX Acquires Leading Interconnection Provider IX Reach
-
IfOnly, the marketplace for experiences, has partnered with the American Red Cross, Get Prepared California, Clear Channel, and iHeart Media to Offer Amazing Experiences for Good
-
ScoreStream scores $2 Million to win the local sports game
-
VytronUS, Inc. Attracts Industry Veteran John Pavlidis as New President and Chief Executive Officer
-
mNectar and Branch Metrics Partner to Bring Optimal User Experience to Mobile Ads
-
Fyusion Closes $13M Venture Round Led by NEA and UTEC
-
Sonatype Named to JMP Securities' Top 50 List of Hottest Privately Held Companies
-
SmartDrive Systems Raises $50 Million and Closes out Record Year
-
FusionOps Launches Application On Salesforce AppExchange
-
FusionOps Raises $12 Million To Accelerate Development and Global Expansion
-
FusionOps Announces Support For Oracle® Enterprise Business Suite
-
Vtesse, Inc. Forms Scientific Advisory Board
-
Form SC 13D/A AMICUS THERAPEUTICS INC Filed by: NEW ENTERPRISE ASSOCIATES 9 L P
-
Hancock Holding Company Announces Five-State Financial Literacy Partnership
-
Cohere Technologies Secures $35 Million in Series C Funding Led by Telstra
-
Form SC 13D CHAMPIONS ONCOLOGY, INC. Filed by: New Enterprise Associates 14, L.P.
-
Critical Outcome Technologies Establishes Advisory Board for the Clinical Development of COTI-2
-
Interleukin Genetics Reports Fourth Quarter and Year-End 2014 Financial Results
-
Form SC 13D/A TARGACEPT INC Filed by: NEW ENTERPRISE ASSOCIATES 10 L P

